Coastline Trust Co Has $1.84 Million Stake in Danaher Co. (NYSE:DHR)

Coastline Trust Co decreased its stake in shares of Danaher Co. (NYSE:DHR) by 3.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned 8,024 shares of the conglomerate’s stock after selling 320 shares during the period. Coastline Trust Co’s holdings in Danaher were worth $1,842,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of DHR. Vanguard Group Inc. lifted its stake in shares of Danaher by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after acquiring an additional 315,912 shares during the period. Geode Capital Management LLC lifted its holdings in Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate’s stock valued at $3,056,996,000 after buying an additional 315,446 shares during the period. Norges Bank bought a new position in Danaher in the fourth quarter valued at approximately $2,130,740,000. Bank of New York Mellon Corp raised its position in shares of Danaher by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after acquiring an additional 441,012 shares during the last quarter. Finally, Fisher Asset Management LLC boosted its position in shares of Danaher by 0.6% in the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock worth $1,051,097,000 after purchasing an additional 26,305 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on DHR shares. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research note on Friday, March 14th. Scotiabank initiated coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. JPMorgan Chase & Co. lowered their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Robert W. Baird set a $231.00 price objective on shares of Danaher in a report on Wednesday. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $274.55.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

DHR opened at $186.71 on Friday. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $133.44 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The business has a fifty day simple moving average of $201.99 and a 200 day simple moving average of $227.23.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business earned $2.09 EPS. Research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.69%. Danaher’s payout ratio is presently 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.